[Federal Register Volume 80, Number 248 (Monday, December 28, 2015)]
[Notices]
[Pages 80777-80778]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32549]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities: Proposed Collection: 
Public Comment Request

AGENCY: Health Resources and Services Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement for opportunity for public 
comment on proposed data collection projects (Section 3506(c)(2)(A) of 
the Paperwork Reduction Act of 1995), the Health Resources and Services 
Administration (HRSA) announces plans to submit an Information 
Collection Request (ICR), described below, to the Office of Management 
and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks 
comments from the public regarding the burden estimate, below, or any 
other aspect of the ICR.

DATES: Comments on this Information Collection Request must be received 
no later than February 26, 2016.

ADDRESSES: Submit your comments to [email protected] or mail the HRSA 
Information Collection Clearance Officer, Room 10C-24, Parklawn 
Building, 5600 Fishers Lane, Rockville, MD 20857.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the data collection plans and 
draft instruments, email [email protected] or call the HRSA 
Information Collection Clearance Officer at (301) 443-1984.

SUPPLEMENTARY INFORMATION: When submitting comments or requesting 
information, please include the information request collection title 
for reference.
    Information Collection Request Title: Sickle Cell Disease Treatment 
Demonstration Program--Quality Improvement Data Collection.
    OMB No. 0915-xxxx-New
    Abstract: In response to the growing need for resources devoted to 
sickle cell disease and other hemoglobinopathies, the United States 
Congress, under Section 712 of the American Jobs Creation Act of 2004 
(Pub. L. 108-357) (42 U.S.C. 300b-1 note), authorized a demonstration 
program for the prevention and treatment of sickle cell disease (SCD) 
to be administered by the Maternal and Child Health Bureau (MCHB) of 
the Health Resources and Services Administration (HRSA) in the U.S. 
Department of Health and Human Services. The program is known as the 
Sickle Cell Disease Treatment Demonstration Program (SCDTDP). The 
SCDTDP is designed to improve access to services for individuals with 
sickle cell disease, improve and expand patient and provider education, 
and improve and expand the continuity and coordination of service 
delivery for individuals with sickle cell disease and sickle cell 
trait. The specific aims for the program are threefold: (1) Increase 
the number of providers treating persons with sickle cell disease, (2) 
increase the number of providers prescribing hydroxyurea, and (3) 
increase the number of providers knowledgeable about treating sickle 
cell disease as well as increase the number of sickle cell patients 
that are seen by providers knowledgeable about sickle cell disease.
    To achieve the goals and objectives of the program, the SCDTDP uses 
quality improvement (QI) methods in a collective impact model which 
supports cross-sector collaboration for achieving measurable effects on 
major social issues. The collective impact model requires shared 
measurement which facilitates tracking progress in a standardized 
method in order to promote learning and enhance continuous improvement.
    Need and Proposed Use of the Information: The purpose of the 
proposed data collection strategy is to implement a system to monitor 
the progress of MCHB-funded activities in improving care and health 
outcomes for individuals living with sickle cell disease/trait and 
meeting the goals of the SCDTDP. Each regional grantee site will be 
asked to report on a core set of evidence-based measures related to 
healthcare utilization among individuals with sickle cell disease and 
the quality of care of the SCD population.
    The data collected for the Sickle Cell Disease Treatment 
Demonstration Program will consist of administrative medical claims 
data collected from State Medicaid Programs and Medicaid Managed Care 
Organizations that administer Medicaid on behalf of states. The data is 
collected either for or by State Medicaid offices for delivery of 
services subject to Medicaid reimbursement.
    The data collection strategy will provide an effective and 
efficient mechanism to do the following: (1) Assess the improvements in 
access to care for sickle cell patients provided by activities in the 
SCDTDP; (2) collect, coordinate, and distribute data, best practices, 
and findings from regional grantee sites to drive improvement on 
quality measures; (3) refine a common model protocol regarding the 
prevention and treatment of sickle cell disease; (4) examine/address 
barriers that individuals and families living with sickle cell disease 
face when accessing quality health care and health education; (5) 
evaluate the grantees' performance in meeting the objectives of the 
SCDTDP; and (6) provide HRSA and Congress with information on the 
overall progress of the program.
    Likely Respondents: Four regional grantee sites funded by HRSA 
under the SCDTDP will be the respondents for this data collection 
activity and submit responses gathered from State Medicaid

[[Page 80778]]

Offices and State Medicaid Managed Care Organizations (MCOs).
    Burden Statement: Burden in this context means the time expended by 
persons to generate, maintain, retain, disclose or provide the 
information requested. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and maintaining information, and disclosing and 
providing information; to train personnel and to be able to respond to 
a collection of information; to search data sources; to complete and 
review the collection of information; and to transmit or otherwise 
disclose the information. The total annual burden hours estimated for 
this Information Collection Request are summarized in the table below.

                                     Total Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                 Number of                       Average burden
          Form name              Number of     responses per   Total responses    per response     Total burden
                                respondents      respondent                        (in hours)         hours
----------------------------------------------------------------------------------------------------------------
SCDTDP Data form............               4  Range:16-80....  Range:64-320...  Range:4-6......  Range:256-1920
                             -----------------------------------------------------------------------------------
    Total...................               4  Range:16-80....  Range:64-320...  Range:4-6......  Range:256-1920.
----------------------------------------------------------------------------------------------------------------

    HRSA specifically requests comments on (1) The necessity and 
utility of the proposed information collection for the proper 
performance of the agency's functions, (2) the accuracy of the 
estimated burden, (3) ways to enhance the quality, utility, and clarity 
of the information to be collected, and (4) the use of automated 
collection techniques or other forms of information technology to 
minimize the information collection burden.

Jackie Painter,
Director, Division of the Executive Secretariat.
[FR Doc. 2015-32549 Filed 12-24-15; 8:45 am]
 BILLING CODE 4165-15-P